Image guidance in the focal treatment of prostate cancer

Current Opinion in Urology

Volumn 22, Issue 4, 2012, Pages 328-335

  Hoang, Anthony N ^a   Volkin, Dmitry ^a   Yerram, Nitin K ^a   Vourganti, Srinivas ^a   Nix, Jeffrey ^a   Linehan, W Marston ^a   Wood, Bradford ^a   Pinto, Peter A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

enhanced ultrasound modalities; focal therapy; multiparametric MRI; prostate cancer

Indexed keywords

CONTRAST MEDIUM; PROSTATE SPECIFIC ANTIGEN;

CANCER DIAGNOSIS; CANCER STAGING; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; DIODE LASER; DRUG EFFICACY; ECHOGRAPHY; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; IMAGE ANALYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT OUTCOME;

BIOPSY; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSTATIC NEOPLASMS; ULTRASONOGRAPHY, INTERVENTIONAL; UNNECESSARY PROCEDURES;

EID: 84862578503     PISSN: 09630643     EISSN: 14736586     Source Type: Journal    
DOI: 10.1097/MOU.0b013e32835482cc     Document Type: Review

References (42)

1. Wolf AM, Wender RC, Etzioni RB, et al. American Cancer Society guideline for the early detection of prostate cancer: update 2010. CA Cancer J Clin 2010; 60:70-98.
2. Lowrance WT, Eastham JA, Yee DS, et al. Costs of medical care after open or minimally invasive prostate cancer surgery: A population-based analysis. Cancer 2011 [Epub ahead of print].
3. Bill-Axelson A, Holmberg L, Filen F, et al. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008; 100:1144-1154.
4. Klotz L. Active surveillance for favorable risk prostate cancer: rationale, results, and vis a vis focal therapy role. Minerva Urol Nefrol 2011; 63:145-153.
5. Onik G, Narayan P, Vaughan D, et al. Focal 'nerve-sparing' cryosurgery for treatment of primary prostate cancer: A new approach to preserving potency. Urology 2002; 60:109-114.
6. Bahn DK, Silverman P, Lee F, et al.. Focal prostate cryoablation: initial results show cancer control and potency preservation. J Endourol 2006; 20:688-692.
7. Ellis DS, Manny TB Jr, Rewcastle JC. Focal cryosurgery followed by penile rehabilitation as primary treatment for localized prostate cancer: initial results. Urology 2007; 70:9-15.
8. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology 2007; 69:1117-1120.
9. Muto S, Yoshii T, Saito K, et al. Focal therapy with high-intensity- focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008; 38:192-199.
10. Onik G, Vaughan D, Lotenfoe R, et al. The male lumpectomy: focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008; 26:500-505.
11. Lindner U, Weersink RA, Haider MA, et al. Image guided photothermal focal therapy for localized prostate cancer: phase I trial. J Urol 2009; 182:1371-1377.
12. Ahmed HU, Hindley RG, Dickinson L, et al. Focal therapy for localized and multifocal prostate cancer: A prospective development study. Lancet Oncol 2012. [Epub ahead of print]
13. Taneja SS, Mason M. Candidate selection for prostate cancer focal therapy. J Endourol 2010; 24:835-841.
14. Ahmed HU, Moore C, Lecornet E, Emberton M. Focal therapy in prostate cancer: determinants of success and failure. J Endourol 2010; 24:819-825.
15. Bott SR, Ahmed HU, Hindley RG, et al. The index lesion and focal therapy: an analysis of the pathological characteristics of prostate cancer. BJU Int 2010; 106:1607-1611.
16. Onik G. The male lumpectomy: rationale for a cancer targeted approach for prostate cryoablation. A review. Technol Cancer Res Treat 2004; 3:365-370.
17. Nelson BA, Shappell SB, Chang SS, et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 2006; 97:1169-1172.
18. Polascik TJ, Mayes JM, Schroeck FR, et al. Patient selection for hemiablative focal therapy of prostate cancer: variables predictive of tumor unilaterality based upon radical prostatectomy. Cancer 2009; 115:2104-2110.
19. Satake N, Ohori M, Yu C, et al. Development and internal validation of a nomogram predicting extracapsular extension in radical prostatectomy specimens. Int J Urol 2010; 17:267-272.
20. Harnden P, Naylor B, Shelley MD, et al. The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis. Cancer 2008; 112: 971-981.
21. Turkbey B, Albert PS, Kurdziel K, Choyke PL. Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 2009; 192:1471-1480.
22. Mitterberger MJ, Aigner F, Horninger W, et al. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection. Eur Radiol 2010; 20:2791-2796.
23. Jiang J, Chen Y, Zhu Y, et al. Contrast-enhanced ultrasonography for the detection and characterization of prostate cancer: correlation with microvessel density and Gleason score. Clin Radiol 2011; 66:732-737.
24. Morelli G, Pagni R, Mariani C, et al. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer. J Urol 2011; 185:2126-2131.
25. Trabulsi EJ, Sackett D, Gomella LG, Halpern EJ. Enhanced transrectal ultrasound modalities in the diagnosis of prostate cancer. Urology 2010; 76:1025-1033.
26. Xie SW, Li HL, Du J, et al. Contrast-enhanced ultrasonography with contrasttuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography. BJU Int 2011 [Epub ahead of print].
27. Zhao HW, Luo JH, Xu HX, et al. The value of contrast-enhanced transrectal ultrasound in predicting the nature of prostate diseases and the Gleason score of prostate cancer by a subjective blood flow grading scale. Urol Int 2011; 87:165-170.
28. Giurgiu CR, Manea C, Crisan N, et al. Real-time sonoelastography in the diagnosis of prostate cancer. Med Ultrason 2011; 13:5-9.
29. Bonekamp D, Jacobs MA, El-Khouli R, et al. Adcements in MR imaging of the prostate: from diagnosis to interventions. Radiographics 2011; 31:677-703.
30. Bouchelouche K, Turkbey B, Choyke P, Capala J. Imaging prostate cancer: an update on positron emission tomography and magnetic resonance imaging. Curr Urol Rep 2010; 11:180-190.
31. Delongchamps NB, Rouanne M, Flam T, et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusionweighted imaging. BJU Int 2011; 107:1411-1418.
32. Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol 2011; 59:477-494.
33. Turkbey B, Mani H, Shah V, et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011; 186:1818-1824.
34. Pinto PA, Chung PH, Rastinehad AR, et al. Magnetic resonance imaging/ ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 2011; 186:1281-1285.
35. Hadaschik BA, Kuru TH, Tulea C, et al. A novel stereotactic prostate biopsy system integrating preinterventional magnetic resonance imaging and live ultrasound fusion. J Urol 2011; 186:2214-2220.
36. Watanabe H, Igari D, Tanahashi Y, et al. Transrectal ultrasonotomography of the prostate. J Urol 1975; 114:734-739.
37. Sauvain JL, Palascak P, Bourscheid D, et al. Value of power doppler and 3D vascular sonography as a method for diagnosis and staging of prostate cancer. Eur Urol 2003; 44:21-30.
38. Sen J, Choudhary L, Marwah S, et al. Role of colour Doppler imaging in detecting prostate cancer. Asian J Surg 2008; 31:16-19.
39. Taverna G, Morandi G, Seveso M, et al. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling. BJU Int 2011; 108:1723-1727.
40. Miyagawa T, Tsutsumi M, Matsumura T, et al. Real-time elastography for the diagnosis of prostate cancer: evaluation of elastographic moving images. Jpn J Clin Oncol 2009; 39:394-398.
41. Pallwein L, Mitterberger M, Struve P, et al. Real-time elastography for detecting prostate cancer: preliminary experience. BJU Int 2007; 100:42-46.
42. Turkbey B, Pinto PA, Mani H, et al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection: histopathologic correlation. Radiology 2010; 255:89-99.